Back to Journals » ClinicoEconomics and Outcomes Research » Volume 8

Determination of the most appropriate method for extrapolating overall survival data from a placebo-controlled clinical trial of lenvatinib for progressive, radioiodine-refractory differentiated thyroid cancer

Total article views   HTML views PDF downloads Totals
14,165 Dovepress* 10,173+ 1,831 12,004
PubMed Central* 3,992 719 4,711
Totals 14,165 2,550 16,715
*Since 30 June 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar